X

Trial Profile

A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Bronchodilatory Effect of MK0476 in Patients With Chronic Asthma.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 05 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Montelukast (Primary) ; Salbutamol
Indications Asthma
Focus Therapeutic Use
Sponsors Merck & Co

Most Recent Events

14 Apr 2010 Actual patient number changed from 64 to 68 as reported by ClinicalTrials.gov.
05 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
22 Jan 2009 Actual initiation date changed from Jun 2008 to Jul 2008 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com